Stålenheim G, Machado L
J Allergy Clin Immunol. 1985 Apr;75(4):508-12. doi: 10.1016/s0091-6749(85)80025-7.
Forty-nine bronchial provocations were performed with different allergens in allergic asthmatic patients. Immediate bronchial reactions occurred in 33 instances, and late reactions occurred in nine instances. The material was divided into three groups according to patients with no reactions, patients with early reactions alone, and patients with late reactions. Titers of whole complement and factors C2 and C3 were determined hemolytically, and the serum protein contents of factors C3, C4, and C1q were measured immunochemically. Decreases in complement and complement components were observed on a number of occasions after bronchial challenge. When the groups were compared with respect to mean change in complement titers, the three groups were indistinguishable. No change was noted in the ratio between the complement contents in venous and arterial blood as a result of provocation, nor did the specific hemolytic activity of factor C3 change. No C3 split products could be traced. It is likely that there will be a higher proportion of patients with C2 consumption among those with late bronchial reactions. No special feature could be assigned to these individuals, however. It is concluded that no major complement activation is regularly found in allergic asthmatic patients as a result of exposure to allergens. However, groups of patients in whom such activation takes place might exist.
对49例过敏性哮喘患者使用不同过敏原进行了支气管激发试验。33例出现即刻支气管反应,9例出现迟发反应。根据无反应患者、仅出现早期反应的患者和出现迟发反应的患者将材料分为三组。采用溶血法测定总补体及C2和C3因子的滴度,采用免疫化学法测定C3、C4和C1q因子的血清蛋白含量。支气管激发后多次观察到补体及补体成分减少。当比较各组补体滴度的平均变化时,三组无明显差异。激发后静脉血和动脉血中补体含量的比值无变化,C3因子的特异性溶血活性也未改变。未检测到C3裂解产物。在出现迟发支气管反应的患者中,C2消耗的患者比例可能更高。然而,这些个体并无特殊特征。得出的结论是,过敏性哮喘患者接触过敏原后通常不会出现主要的补体激活。然而,可能存在发生这种激活的患者群体。